NCT04375631 2026-03-05CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaFred Hutchinson Cancer CenterPhase 1 Recruiting120 enrolled
NCT04195633 2026-02-27Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesFred Hutchinson Cancer CenterPhase 2 Recruiting60 enrolled
NCT05589896 2026-02-24A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesOssium Health, Inc.Phase 1/2 Recruiting12 enrolled
NCT02143830 2025-11-12RAFAChildren's Hospital Medical Center, CincinnatiPhase 2 Recruiting70 enrolled
NCT06928662 2025-11-06Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of RelapseFred Hutchinson Cancer CenterPhase 1/2 Recruiting36 enrolled